Loading
Latest filing published 30 Jul 2018 for Medite Cancer Diagnostics, Inc., €8,589.
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Our data holds just one disclosure by Stephen L. Von Rump, dated 30 July 2018, reporting an open-market purchase worth €8,589 in Medite Cancer Diagnostics, Inc. Further filings will be added here. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration